Paula Ramirez-Palacios

Dr. Paula Ramirez-Palacios

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2016 in Salud Pública de México
Verified
Journal Article
Open access
EDEdgar Denova-Gutiérrez
Edgar Denova-Gutiérrez
YFYvonne N. Flores
Yvonne N. Flores
KGKatia Gallegos-Carrillo
Katia Gallegos-Carrillo
PRPaula Ramirez-Palacios
Paula Ramirez-Palacios
BRBerenice Rivera-Paredez
Berenice Rivera-Paredez
JSJorge Salmerón
Jorge Salmerón
Objective. To examine different health outcomes that are associated with specific lifestyle and genetic factors. Materials and methods. From March 2004 to April 2006, a sample of employees from three different health and academic institutions, as well as their family members, were enrolled in the study after providing informed consent. At baseline and follow-up (2010-2013), participants completed a self-administered questionnaire, a physical examination, and provided blood samples. Results. A total of 10 729 participants aged 6 to 94 years were recruited at baseline. Of these, 70% were females, and 50% were from the Mexican Social Security Institute. Nearly 42% of the adults in the sample were overweight, while 20% were obese. Conclusion. Our study can offer new insights into disease mechanisms and prevention through the analysis of risk factor information in a large sample of Mexicans.

6 May 2020 in BMJ
Verified
Journal Article
Open access
PDF file
LSLuz María Sánchez-Romero
Luz María Sánchez-Romero
FCFrancisco Canto-Osorio
Francisco Canto-Osorio
RGRomina González-Morales
Romina González-Morales
MCM Arantxa Colchero
M Arantxa Colchero
SNShu-Wen Ng
Shu-Wen Ng
TBTonatiuh Barrientos-Gutiérrez
Tonatiuh Barrientos-Gutiérrez
Objective To examine changes in categories of soft drink consumption in a cohort of Mexican adults, three years after the implementation of the sugar sweetened beverage tax. Design Open cohort longitudinal analysis. Setting Three waves of the Health Workers Cohort Study, Mexico, spanning 2004 to 2018. Participants 1770 people aged 19 years or older with information on drinks consumption available in at least one of the three cohort waves. Main outcome measure Change in probability of belonging to one of four categories of soft drinks consumption (non, low, medium, high) after the tax was implemented. Heterogeneity of associations by income and education was also assessed. Results Before the implementation of the tax, more than 50% of the participants were medium and high consumers of soft drinks and less than 10% were in the non-consumer category. After the tax was implemented, 43% of the population was categorised as medium or high consumers and the prevalence of non-consumers increased to 14%. Three years after implementation of the tax on 1 January 2014, the probability of being a non-consumer of soft drinks increased by 4.7 (95% confidence interval 0.3 to 9.1) percentage points and that of being a low consumer increased by 8.3 (0.6 to 16.0) percentage points compared with the pre-tax period. Conversely, the probability of being in the medium and high levels of soft drinks consumption decreased by 6.8 (0.5 to 13.2) percentage points and 6.1 (0.4 to 11.9) percentage points, respectively. No significant heterogeneity of the tax across income levels was observed, but stronger effects of the tax were seen in participants with secondary school education or higher, compared with those with elementary school or less. Conclusions The Mexican sugar sweetened beverage tax was associated with a reduction in the probability of consuming soft drinks in this cohort of employees from a healthcare provider. The results cannot be extrapolated to the Mexican population, but they suggest that three years after implementation, the tax had helped to increase the proportion of people who do not consume soft drinks while decreasing the proportion of high and medium consumers.

1 December 2018 in Gene
Verified
Journal Article
Closed access
EREric Ramirez-Salazar
Eric Ramirez-Salazar
SCSergio Carrillo-Patiño
Sergio Carrillo-Patiño
AHAlberto Hidalgo-Bravo
Alberto Hidalgo-Bravo
BRBerenice Rivera-Paredez
Berenice Rivera-Paredez
MQManuel Quiterio
Manuel Quiterio
RVRafael Velazquez-Cruz
Rafael Velazquez-Cruz

12 October 2019 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
FGFRIDA Study Group
FRIDA Study Group
RHRubí Hernández-López
Rubí Hernández-López
ALAttila T. Lorincz
Attila T. Lorincz
LTLeticia Torres-Ibarra
Leticia Torres-Ibarra
CRCaroline Reuter
Caroline Reuter
JSJorge Salmerón
Jorge Salmerón
Background: Vigilant management of women with high-risk human papillomavirus (hrHPV) is necessary in cancer screening programs. To this end, we evaluated the performance of S5 (targeting DNA methylation in HPV16, HPV18, HPV31, HPV33, and human gene EPB41L3) to predict cervical intraepithelial neoplasia grade 2 or higher (CIN2+) in a sample of hrHPV-infected women referred to colposcopy in the FRIDA Study, a large screening trial in Mexico. A nested case-control sample with women referred to colposcopy either by atypical squamous cells of undetermined significance or higher (ASCUS+) in cytology and/or positive for HPV types 16 or 18 was tested by S5. Seventy-nine cases of CIN2+ were age-matched to 237 controls without a diagnosis of CIN2+ (<CIN2). DNA from exfoliated cervical cells was bisulfite converted and PCR amplified for S5 targets, and methylation was quantified at specific cytosines by pyrosequencing. Results: The S5 classifier separated women with CIN2+ from <CIN2 with a highly significant area under the curve (AUC) of 0.75 (95% CI 0.69–0.82), while AUC for CIN3+ was 0.81 (95% CI 0.74–0.89). To optimize sensitivity and specificity for Mexico, an alternative S5 cutoff of 3.7 was implemented to account for overall higher methylation seen in our already triaged women. All three invasive cancers were detected by methylation or HPV16/18 but none by cytology. Sensitivity of S5 for CIN2+ was 62% (95% CI 50.4–72.7%), specificity was 73% (95% CI 66.9–78.5%), and adjusted PPV was 15.1% (95% CI 12.0–18.3%). In contrast, the crude sensitivity of HPV16/18 detection and cytology were 63.3% (95% CI 51.7–73.9%) and 57.0% (95% CI 45.3–68.1%) respectively; specificity was 29.1% (95% CI 23.4–35.3%) and 62.4% (95% CI 55.9–68.6%) respectively, while adjusted PPV was 6.4% (95% CI 4.9–8.1%) and 10.5% (95% CI 8.0–13.1%), respectively. Methylation testing could reduce colposcopy referrals by 30 to 50% with virtually no loss of sensitivity for CIN2+ and CIN3+. Conclusions: S5 testing on hrHPV-positive women significantly increased diagnostic information compared to triage by HPV16/18 plus cytology and appears to have clinical utility as an additional test to substantially lessen burdens on colposcopy. Trial registration: The FRIDA Study is registered in ClinicalTrials.gov, number NCT02510027.

21 November 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
MMMayeli M. Martínez-Aguilar
Mayeli M. Martínez-Aguilar
DADiana I. Aparicio-Bautista
Diana I. Aparicio-Bautista
EREric Ramirez-Salazar
Eric Ramirez-Salazar
JRJuan Pablo Reyes-Grajeda
Juan Pablo Reyes-Grajeda
Aldo H de la Cruz-MontoyaAldo H de la Cruz-Montoya
Aldo H de la Cruz-Montoya
RVRafael Velazquez-Cruz
Rafael Velazquez-Cruz
Osteoporosis is a skeletal disease mainly affecting women over 50 years old and it represents a serious public health problem because of the high socioeconomic burden. This disease is characterized by deterioration of bone microarchitecture, low bone mineral density (BMD), and increased risk of fragility fractures. This study aimed to identify serum useful proteins as biomarkers for the diagnosis and/or prognosis of osteoporosis and fracture risk. We collected 446 serum samples from postmenopausal women aged ≥45 years old. Based on the BMD measurement, we classified the participants into three groups: osteoporotic, osteopenic, and normal. In an initial discovery stage, we conducted a proteomic approach using two-dimensional differential gel electrophoresis (2D-DIGE). The peptides into the spots of interest were identified through matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF). Enzyme-linked immunosorbent assay (ELISA) was performed to validate the proteins of interest. We identified 27 spots of interest when comparing low BMD versus normal BMD postmenopausal women. Based on their relevance in bone metabolism, we analyzed three proteins: ceruloplasmin (CP), gelsolin (GSN), and vitamin D-binding protein (VDBP). Our results demonstrated that low serum VDBP levels correlate with low BMD (osteopenic and osteoporotic). Therefore, VDBP could be considered as a novel, potential, and non-invasive biomarker for the early detection of osteoporosis.

14 June 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
BRBerenice Rivera-Paredez
Berenice Rivera-Paredez
LMLuis Rodrigo Macias
Luis Rodrigo Macias
Juan Carlos Fernandez-LopezJuan Carlos Fernandez-Lopez
Juan Carlos Fernandez-Lopez
MVMarisela Villalobos-Comparán
Marisela Villalobos-Comparán
MMMayeli M. Martinez-Aguilar
Mayeli M. Martinez-Aguilar
RVRafael Velazquez-Cruz
Rafael Velazquez-Cruz
Risk of hyperuricemia is modified by genetic and environmental factors. Our aim was to identify factors associated with serum uric acid levels and hyperuricemia in Mexicans. A pilot Genome-wide association study GWAS was performed in a subgroup of participants (n = 411) from the Health Workers Cohort Study (HWCS). Single nucleotide polymorphisms (SNPs) associated with serum uric acid levels were validated in all the HWCS participants (n = 1939) and replicated in independent children (n = 1080) and adult (n = 1073) case-control studies. The meta-analysis of the whole HWCS and replication samples identified three SLC2A9 SNPs: rs1014290 (p = 2.3 × 10−64), rs3775948 (p = 8.2 × 10−64) and rs11722228 (p = 1.1 × 10−17); and an ABCG2 missense SNP, rs2231142 (p = 1.0 × 10−18). Among the non-genetic factors identified, the visceral adiposity index, smoking, the metabolic syndrome and its components (waist circumference, blood pressure, glucose and hyperlipidemia) were associated with increased serum uric acid levels and hyperuricemia (p < 0.05). Among the female HWCS participants, the odds ratio for hyperuricemia was 1.24 (95% CI, 1.01–1.53) per unit increase in soft drink consumption. As reported in other studies, our findings indicate that diet, adiposity and genetic variation contribute to the elevated prevalence of hyperuricemia in Mexico.